摘要:
The objective of the present invention is to provide a laminated phase retarder film that is superior in evenness, exhibits a biaxial optical property as a whole, and makes it possible to set the biaxial optical property over a wide range. This object is achieved by a laminated phase retarder film comprising a transparent resin film as a substrate and at least one coat layer having a refractive-index anisotropy laminated on at least one surface of the substrate, wherein a in-plane retardation value (R0) is not less than 20 nm, a retardation value (R′) in the film-thickness direction, which is calculated from a retardation value (R40) measured by inclining by 40 degrees around the slow axis of the film and the in-plane retardation value (R0), is greater than 40 nm.
摘要:
A phase retarder film is provided wherein at least one oblique evaporation layer comprising an inorganic dielectric mainly containing TiO.sub.2 is formed on at least one surface of a transparent polymer film with an intermediate layer between, the evaporation layer having positive refractive index anisotropy and a principal optic axis tilted 20 degrees to 70 degrees from a normal direction to said transparent polymer film. The phase retarder film is suitable for improving viewing angle characteristics of the TN-LCD.
摘要:
A phase retarder including a layered inorganic compound-containing sheet or layered inorganic compound-containing film, the inorganic compound being selected from the group consisting of a clay mineral, a chalcogen compound, a zirconium phosphate compound, an oxyacid salt of a transition metal, a layered polysilicate, a metal oxyhalogenide, and an intercalary decoration thereof intercalated with ions or molecules between crystalline layer units, the inorganic compound having a mean particle size of 5000 nm or less and a stratified structure with a plurality of crystalline layer units wherein the phase retarder has a refractive index in the plane of the phase retarder that is different from a refractive index in the thickness direction of the phase retarder.
摘要:
A system or kit for analysis of phosphatase comprising a reagent I containing NADP or NADPH as a main component, and a reagent II containing components for color-development signal amplification utilizing NAD-NADH interconversion, wherein at least one of the hydrogen donors participating in the NAD-NADH interconversion is included in reagent I, but not in reagent II, which eliminates the necessity that the reagent II is further separated into two parts. This enables the preparation of reagent II as a mixture which can be readily used and which can be preserved for a long period of time without "reagent blank" occurring. Additionally, the present kit eliminates the necessity of mixing reagents I and II immediately before actual use and thus permits periodical analysis of samples with a reagent having the same components for long time periods with reliable and uniform sensitivity.
摘要:
A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.
摘要:
A cast-molding material for a plastic lens which is almost free from causing defective dyeing when dyed, and a process for producing plastic lenses almost free from causing defective dyeing, the cast-molding material containing, as essential components, a combination of (A) diethylene glycol bisallylcarbonate or a mixture of diethylene glycol bisallylcarbonate and a monomer copolymerizable therewith, with (B) a polyether-modified silicone compound, and the process including cast-molding the above cast-molding material in a mold.
摘要:
As a phase retarder film in which at least one oblique evaporation layer of an inorganic dielectric having positive refractive index anisotropy and having its principal optic axis tilted 20 degrees to 70 degrees from the direction of the normal to the film is formed on at least one surface of a transparent polymer film with an intermediate layer between, a large area film is easily and inexpensivly obtained.
摘要:
Disclosed is a phase retarder film made of a thermoplastic resin having an in-plane retardation of 50 to 300 nm and a ratio of the in-plane retardation to the retardation normal to the plane of not less than 0.5, but not more than 1.8, a process for the production thereof and a laminate phase retarder film using said phase retarder film above.
摘要:
A phase retarder and a process for producing the same are disclosed. The phase retarder is obtained by shrinking a uniaxially stretched thermoplastic high polymer film in the direction perpendicular to the stretching direction at a lengthwise shrink of at least 2%. The phase retarder has a ratio of a retardation value (R.sub.30) measured on the phase retarder being inclined at a angle of 30.degree. with respect to the orientation axis as an axis of rotation to a retardation value (R.sub.0) measured on the phase retarder being held horizontally, each measured with a polarizing microscope, (R.sub.30 /R.sub.0) of not more than 1.10, and preferably not more than 1.07. A liquid crystal display fitted with the phase retarder exhibits broad viewing angle characteristics while achieving a satisfactory B/W display level.
摘要:
A human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of human CC chemokine receptor 4 (CCR4) but does not react with a human blood platelet; a human CDR-grafted antibody or the antibody fragment thereof which specifically reacts with the extracellular region of CCR4 and has a cytotoxic activity against a CCR4-expressing cell; and a medicament, a therapeutic agent or a diagnostic agent comprising at least one of the antibodies and the antibody fragments thereof as an active ingredient.